Abiopharma

🔍 Howard Kevin D (Executive)

Company: CHARTER COMMUNICATIONS, INC. /MO/ (CHTR)

Report Date: 2026-07-27

Detailed Transactions and Holdings:

• Acquired 901 shares of Stock Options at $128.2 per share (Derivative)
  Date: 2026-07-27 | Code: A | Expires: 2036-07-27 | Exercise: 2029-07-27 | equity_swap_involved: 0 | shares_owned_after: 901.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 234 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-27 | Code: A | Exercise: 2029-07-27 | equity_swap_involved: 0 | shares_owned_after: 234.00 | transaction_form_type: 4 | Footnotes: F2, F3, F2

Footnotes:

• F1: Stock Options granted on July 27, 2026, under the Charter Communications, Inc. 2019 Stock Incentive Plan; 100% of the grant will vest on the third anniversary of the grant date, July 27, 2029. Such options will terminate 10 years from the grant date unless terminated sooner in accordance with the plan or grant agreement.
• F2: Restricted Stock Unit grant - price and expiration date not applicable.
• F3: Restricted Stock Units granted on July 27, 2026, under the Charter Communications, Inc. 2019 Stock Incentive Plan; 100% of the grant will vest on the third anniversary of the grant date, July 27, 2029.